Global Clotrimazole Vaginal Cream Market Size, Share and Trends Analysis Report, By Type (15g, 30g, and 45g), By Application (Foot Ailment, Jock Itch, Ringworm, and Yeast Infections), and By Distribution Channel (Hospitals, Drug Stores, and Others), Forecast 2022-2028

The global clotrimazole vaginal cream market is anticipated to grow at a significant CAGR during the forecast period 2022-2028.  Clotrimazole vaginal cream is a prescription treatment for fungal diseases such as athlete’s foot, jock itch, ringworm, and yeast infections (cutaneous candidiasis, vaginal candidiasis, and superficial dermatologic Infections). It belongs to the topical antifungal family of medicines. It can be used on its own or in combination with other drugs. According to NCBI, athlete’s foot is a frequent ailment among athletes. Between 3% to 15% of the population is estimated to have ailment issues. It is more common among men and the elderly. According to the Centre for Disease Control and Prevention (CDC), vaginal candidiasis is common in the US, it is the second most common type of vaginal infection after bacterial vaginal infections as of 2020. An estimated 1.4 million outpatient visits for vaginal candidiasis occur annually in the US.

The hospital sub-segment is anticipated to propel the overall growth of the market owing to the increasing cases of infectious skin diseases such as jock itch, ringworm, and yeast infections among others. The rise in the adoption of clotrimazole products in hospitals for the treatment of these infectious skin diseases is the major cause of the growth of the segment. Clotrimazole is a topical antifungal that is used to treat yeast infections on the skin. It works by eradicating the infection-causing yeast. The treatment of such infectious diseases is done in hospitals and therefore, the segment is propelling the growth of the market.

Some major players in the market include Bayer AG, Glenmark Pharmaceuticals Ltd., G&W laboratories Inc., Lannett Co. Inc., Perrigo Co. PLC, Mylan NV, Lupin Inc., Taro Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. among others. The market players are helping significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay in the competition of the market. For instance, in September 2020, Cipla’s consumer healthcare subsidiary Cipla Health announced its foray into the antifungal product category with the introduction of Clocip, a skin infection solution. The solution is available in two forms, the Clocip Clotrimazole Absorbent Dusting Powder and Clocip Clotrimazole Cream having special formulated antibacterial and antifungal properties to treat skin infections and prevent them from recurring.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Bayer AG, Glenmark Pharmaceuticals Ltd., G&W laboratories Inc., Lannett Inc., Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc.,and Teva Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How are playersaddressing challenges to sustain growth?
• Where is the investment opportunity?

Global Clotrimazole Vaginal Cream Market Report by Segment

By Type

• 15g
• 30g
• 45g

By Application

• FootAilment
• Jock Itch
• Ringworm
• Yeast infections

By Distribution Channel

• Hospitals
• Drug Stores
• Others

Global Clotrimazole Vaginal Cream Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa